Keyword: Surface Oncology
Surface Oncology’s Detlev Biniszkiewicz and Scott Chappel jumped to MPM Capital as executive partners to help identify oncology startup ventures.
A quiet immuno-oncology startup that just began clinical tests and a rare disease are both looking to raise funding on the U.S. IPO market.
Goater landed the post with a résumé that lists a starring role in Voyager Therapeutics’ IPO and a decade in investment banking among its highlights.
Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.